Introduction acid binding protein aP2 (Tontonoz et al., 1994a) , phosphoenolpyruvate carboxykinase (Tontonoz et al., 1995) , The deposition of cholesterol ester within cells of the lipoprotein lipase (Schoonjans et al., 1996) , and the artery wall is fundamental to the pathogenesis of atherobrown fat uncoupling protein UCP1 (Sears et al., 1996) . sclerosis (Brown and Goldstein, 1983; The thiazolidinedione class of antidiabetic drugs and 1989). Atherogenic cholesterol-rich diets lead to an in-15-deoxy-⌬ 12,14 -prostaglandin J2 (15d-PGJ2) have been crease in monocyte adherence to arterial endothelium identified as ligands for this receptor, facilitating analyand their subsequent migration into the subendothelial sis of its biologic function ; Kliewer space, where they take up large amounts of cholesterol et al., 1995; Lehmann et al., 1995) . PPAR␥ is expressed ester. These cholesterol-laden macrophages are known at highest levels in adipose tissue and serves a central as foam cells, and it is the accumulation of these cells regulator of the process of adipocyte differentiation beneath the endothelium that forms the earliest grossly (Chawla et al., 1994; Tontonoz et al. 1994b ). However, recognizable atherosclerotic lesion, the fatty streak (Stary mounting evidence suggests that this transcription facet al., 1994 ). An understanding of the mechanisms by tor may also play an important role in the regulation of which monocytes accumulate LDL cholesterol is central lipid metabolism in other cell types, such as mammary to an understanding of the early stages of atherogenesis.
and colonic epithelium (Mueller et al., 1998) . The observation that patients lacking functional LDL PPAR␥ has been reported to be expressed in several receptors still develop atherosclerotic lesions rich in myeloid leukemia cell lines (Greene et al., 1995) , alfoam cells led to the discovery of the "scavenger paththough its biologic function in hematopoetic cells has way" for LDL uptake (Goldstein et al., 1979; Buja et al., not been defined. Given the established role of this nu-1983). Macrophages express relatively few receptors for clear receptor as a regulator of adipocyte differentiation, native LDL, and these receptors are down-regulated in we explored whether PPAR␥ might serve a similar function in myelomonocytic cells. In the following work, we outline a novel signaling pathway for the regulation of
To whom correspondence should be addressed. # These authors contributed equally to this work. monocyte differentiation and lipid metabolism mediated by the PPAR␥:RXR heterodimer. These findings suggest in tissue macrophages, we performed immunohistochemistry on sections of murine lymph node. As shown an unexpected role for nuclear receptors in the pathoin Figures 1E and 1F, the nuclei of the macrophages in genesis of atherosclerosis.
these sections show strong staining (purple) for PPAR␥ (arrows). By contrast, no staining is seen in the lymphoResults cyte nuclei.
Expression of PPAR␥ Protein in Peripheral Blood Regulation of PPAR␥ Expression during Monocytes and Tissue Macrophages
Myelomonocytic Differentiation The expression of PPAR␥ in spleen and myelomonocytic
The human leukemia cell line HL60 was used to begin leukemia cells (Greene et al., 1995) , led us to search for to characterize the role of PPAR␥ in monocytic cells. its expression in normal peripheral blood monocytes HL60 cells display controlled differentiation along the and tissue macrophages. To address this issue, we pergranulocyte or the monocyte lineage in response to variformed immunofluorescence microscopy using immuous inductive signals. For example, retinoic acid recepnoaffinity-purified antisera raised against the N terminus tor (RAR) ligands such as 9-cis retinoic acid and the of human PPAR␥. The ability of this antisera to detect synthetic retinoid AM580 are inducers of HL60 granulo-PPAR␥ protein in cells was verified using cultured 3T3-cytic differentiation, while 1,25-dihydroxyvitamin D3 and L1 preadipocytes, which have been shown to express TPA promote monocytic differentiation. Expression of PPAR␥ (Chawla et al., 1994; Tontonoz et al., 1994b) . A PPAR␥ mRNA during HL60 cell differentiation was analow level of background cytoplasmic staining but no lyzed by Northern blotting. As shown in Figure 2A , a nuclear staining was seen with preimmune sera ( Figure  3 -to 5-fold increase in PPAR␥ expression was observed 1A). Distinct punctate nuclear staining of 3T3-L1 cells when HL60 cells were treated for 5 days with either 40 was seen with the PPAR␥ antiserum (Figures 1B and nM 1,25-dihydroxyvitamin D3 or for 24 hr with 40 ng/ml 1C). Most of the cells in Figure 1B are undifferentiated TPA. No change in PPAR␥ expression was seen after 5 preadipocytes and stain weakly for PPAR␥; however, a days of treatment with 40 nM AM580. Thus, expression single differentiated adipocyte with obvious cytoplasmic of PPAR␥ in this cell line is induced by agents known lipid accumulation stains very strongly (arrow). This is to trigger monocytic differentiation. consistent with the known differentiation-dependent expression of PPAR␥ in 3T3-L1 cells. A similar pattern of PPAR␥ and RXR Ligands Promote the Differentiation punctate nuclear staining is observed in human periphof Myelomonocytic Cells eral blood monocytes with anti-PPAR␥ antisera ( Figure  Next we asked whether ligand activation of the PPAR␥ pathway could influence maturation of HL60 cells. Cells 1D). To determine whether PPAR␥ was also expressed expression of the lipopolysaccharide receptor CD14 is selectively induced during monocytic differentiation (Lubbert et al., 1991) . Following culture for 5 days in the presence of various combinations of receptor-specific ligands, surface antigen expression was analyzed by flow cytometry. As expected, the RAR-specific retinoid AM580 was an effective inducer of CD18 and CD11b, but had only a small effect on CD14 expression ( Figures  3A and 3B ). In contrast, BRL49653, 15d-PGJ2, or LG268 alone induced CD18, CD11b, and CD14 expression, and simultaneous treatment with PPAR␥ and RXR ligands had a synergistic effect on all three markers ( Figure 3 and data not shown). The magnitude of the change in surface CD14 expression is underscored by the distinct shift in the fluorescence intensity of the counted population ( Figure 3B, insert) .
To determine whether the expression of PPAR␥ was required for induction of monocyte markers by these agonists, we examined their effect on the HL60-derived leukemia cell line CDM-1. This cell line has an intact RXR signaling pathway (Nagy et al., 1995) ; however, it does not express PPAR␥ ( Figure 3C , insert). Treatment of CDM-1 cells with 15d-PGJ2 and LG268 had no effect PPAR␥ and RXR-specific ligands resulted in a synergistic induction of surface CD14 expression ( Figure 3D ). Note that this induction is equivalent in magnitude to were cultured for 5 days in the presence of either 9-cis that seen with TPA, a known inducer of monocytic differretinoic acid (9-cis RA; 100 M), the natural PPAR␥ lientiation. As expected, an induction of CD14 expression gand 15d-PGJ2 (3 M), the synthetic PPAR␥ ligand was also seen following treatment with 1,25-dihydroxy-BRL49653 (5 M), the RXR-specific retinoid LG268 (100 vitamin D3. nM; Boehm et al., 1995) , or the combination of a PPAR␥ We also examined the ability of PPAR␥ ligands to ligand and LG268. As anticipated, HL60 cells treated modulate surface marker expression in primary cultures with 9-cis RA exhibited a reduction in cell growth, an of human peripheral blood monocytes. As shown in Figinduction of oxidative burst capacity as measured by NBT ure 3E, treatment of monocytes with PPAR␥ activators reduction assay, and distinct changes in nuclear morfrom each of three different chemical classes, troglitaphology ( Figure 2B and data not shown). Unexpectedly, zone, 15d-PGJ2, or oxLDL (Nagy et al., 1998, lesions are derived primarily from macrophages, the the macrophage response to high extracellular concentrations of oxLDL. lipid metabolism of these cells is of particular relevance to human disease. Foam cells arise in a microenvironment characterized by high local concentrations of oxidized lipoproteins. Accordingly, we considered the pos-PPAR␥ and RXR Ligands Stimulate Uptake of OxLDL by THP-1 Cells sibility that expression of PPAR␥ might be modulated in response to such environmental conditions. THP-1
Since oxLDL stimulated PPAR␥ expression, we speculated that PPAR␥ and RXR ligands may promote uptake cells were cultured for 5 days in the presence of LG268 and 50 g/ml native or modified human LDL, and the of oxLDL by monocytic cells such as THP-1. Following treatment with PPAR␥ and RXR ligands, THP-1 cells expression of PPAR␥ mRNA analyzed by Northern blotting. While treatment of THP-1 cells with LG268 alone were incubated for 4 hr with increasing concentrations of DiI-labeled oxLDL and cell-associated fluorescence had no effect on expression of PPAR␥ mRNA, simultaneous treatment with oxLDL and LG268 resulted in a quantitated by flow cytometry. As shown in Figure 5A , treatment with either 15d-PGJ2 and LG268 or troglitasignificant induction ( Figure 4C ). A smaller increase in PPAR␥ expression was observed when THP-1 cells were zone and LG268 led to a significant increase in cell association (a combination of binding and uptake) of treated with oxLDL alone (data not shown). Surprisingly, the ability to induce PPAR␥ expression was specific for DiI-oxLDL. The specificity of this effect for modified lipoprotein was verified using an an excess of unlabeled oxidatively modified LDL and was not observed with either native or acetylated LDL (acLDL). We also examlipoprotein as competitor ( Figure 5B ). While an excess of oxLDL abolished PPAR␥-induced association, native ined PPAR␥ expression in primary human peripheral blood monocytes cultured in the presence or absence LDL did not compete. This specificity for modified LDL is characteristic of macrophage scavenger receptors. of 50 g/ml oxLDL. Figure 4C (right) shows that exposure of human monocytes to oxLDL strongly induced PPAR␥ In order to determine whether oxLDL was actually internalized by PPAR␥-activated THP-1 cells, control expression. Primary monocytes were more responsive than THP-1 cells to oxLDL and did not require LG268 and 15d-PGJ2/LG268-treated cultures were incubated for 4 hr with 20 g/ml DiI-oxLDL and examined by fluofor maximal induction of PPAR␥. These results established a link between oxLDL and the PPAR␥ signaling rescence microscopy. As demonstrated in Figures 5C and 5D, THP-1 cells treated with these activators showed pathway, and suggested that PPAR␥ may play a role in analyzed were able to induce significant expression of mRNA encoding SR-A type I ( Figure 6A ) or SR-A type II (data not shown). In fact, troglitazone antagonized the induction of SR-A type I by TPA. Similar results were obtained when 15d-PGJ2 was used as the PPAR␥ ligand (data not shown).
We further examined the effect of PPAR␥:RXR ligands on surface expression of CD36 by flow cytometry. As shown in Figure 6B , treatment of THP-1 cells and primary human monocytes with either troglitazone or oxLDL alone induced a significant change in CD36 expression. Consistent with the Northern analysis ( Figure 6A ), simultaneous treatment with LG268 had a synergistic effect. We also directly compared the ability of PPAR␥:RXR ligands to modulate surface expression of CD36 and SR-A. Figure 6C demonstrates that while TPA was an effective inducer of both CD36 and SR-A expression on THP-1 cells, the combination of 15d-PGJ2 and LG268 selectively induced expression of CD36. Similar results were obtained when troglitazone was used as the PPAR␥ stimulation of oxLDL binding by PPAR␥:RXR ligands RXR pathway in these cells stimulates both binding and were linked, we utilized a monoclonal antibody to CD36 uptake of oxLDL.
(OKM5) that has been demonstrated previously to interfere with the binding of oxLDL (Endemann et al., 1993) .
PPAR␥ and RXR Ligands Regulate Expression
Following 5 days of culture in the presence of 15d-PGJ2 of the Scavenger Receptor CD36
and LG268, THP-1 cells were incubated for 3 hr at 4ЊC The ability of PPAR␥ and RXR ligands to stimulate oxLDL with 10 g/ml DiI-oxLDL in the presence of OKM5 or uptake was likely to be the result of increased surface control IgG monoclonal antibody and cell association expression of one or more macrophage scavenger requantitated by flow cytometry. An excess of unlabeled ceptors. The two receptors most conclusively linked to oxLDL (200 g/ml) served as a control for the specificity oxLDL uptake are CD36 and SR-A (type I and II). Northof oxLDL binding. As shown in Figure 6C , the anti-CD36 ern analysis was used to monitor expression of the antibody was an effective inhibitor of DiI-oxLDL binding, mRNAs encoding these receptors in THP-1 cells followresulting in a 65% reduction in total cell association and ing treatment with various nuclear receptor ligands. a 75% reduction in specific association (as defined by Unstimulated THP-1 cells do not express significant competition with 20-fold excess of oxLDL). While it is amounts of mRNA for either CD36 or SR-A. TPA has possible that other scavenger receptors may make mibeen reported previously to be an effective inducer of nor contributions to PPAR␥:RXR-induced oxLDL assoboth CD36 and SR-A type I expression in THP-1 cells ciation, these data indicate that the effect is mediated (Moulton et al., 1992; Yesner et al., 1996;  Figure 6A ). As primarily by the scavenger receptor CD36. shown above for HL60 cells, TPA also induces expression of PPAR␥ in THP-1 cells. Treatment of THP-1 cells with either troglitazone alone or LG268 alone resulted
The CD36 Promoter Is a Direct Target of the PPAR␥:RXR␣ Heterodimer in a small increase in CD36 mRNA expression; however, the combination of both ligands was almost as effective
The observation that CD36 mRNA was increased upon treatment with PPAR␥ and RXR activators raised the as TPA. Moreover, the combination of troglitazone and TPA led to an additive induction of CD36 mRNA exprespossibility that CD36 might be a direct target of the PPAR␥:RXR heterodimer. To determine whether PPAR␥ sion. Interestingly, none of the nuclear receptor ligands could function to regulate transcription of the CD36 proTo confirm that this site was mediating the observed induction of the CD36 promoter by PPAR␥:RXR␣, we moter, the region corresponding to Ϫ273 to ϩ47 of the CD36 promoter (Armesilla and Vega, 1994 ) was cloned constructed a second CD36 promoter-luciferase reporter containing the sequence from Ϫ263 to ϩ47, into the luciferase reporter vector pGL-BASIC (Ϫ273/ luc). This construct was cotransfected with CMX-mPPAR␥ which lacks the PPAR␥ binding site (Ϫ263/luc). The Ϫ263/luc construct showed minimal responsiveness to and CMX-hRXR␣ expression vectors into CV-1 cells. Following transfection, the cells were treated with vehi-PPAR␥ ( Figure 7A ). Collectively, these results suggest that the PPAR␥:RXR␣ heterodimer modulates CD36 cle or the PPAR␥-specific ligand BRL49653. Figure 7A demonstrates that the PPAR␥:RXR␣ heterodimer actigene expression through direct interaction with the proximal promoter. vated transcription of the Ϫ273/luc construct in a liganddependent manner.
The PPAR␥:RXR complex activates transcription of
PPAR␥ Is Expressed in the Foam Cells of Atherosclerotic Lesions target genes by binding to DR-1 (direct repeat with one nucleotide spacer) type hormone response elements
The above findings raise the intriguing possibility that PPAR␥ may be involved in the regulation of foam cell (Kliewer et al., 1992b) . We analyzed the promoter region of the CD36 gene (Armesilla and Vega, 1994) and identilipid metabolism in vivo. A pivotal question, then, is whether PPAR␥ is actually expressed in the foam cells fied a sequence (Ϫ273 to Ϫ260) with homology to a DR-1 motif ( Figure 8B ). The ability of a synthetic oligonuof atherosclerotic lesions. In fact, very few transcription factors have ever been shown to be present at detectcleotide spanning this region to bind PPAR␥ was investigated by gel mobility shift assay using nuclear extracts able levels in foam cells. Expression of PPAR␥ protein in atherosclerotic lesions was examined by immunohisprepared from 3T3-F442A adipocytes and THP-1 cells. As shown in Figure 7B , a single nucleoprotein complex tochemistry using sections of aorta from a mouse that carries human apoB and apo(a) transgenes and lacks was bound by the CD36 DR-1 oligonucleotide using either nuclear extract. This complex was competed by a expression the LDL receptor (Sanan et al., 1998) . These mice develop atherosclerosis spontaneously at a young 50-fold excess of unlabeled CD36 DR-1 oligonucleotide (spf), but not by a similar excess of an oligonucleotide age when fed a normal diet. Subscapular brown adipose tissue was used a control for PPAR␥ expression. As with a mutation in the DR-1 site (mut). Moreover, the complex was abolished and a supershift formed when seen in Figure 8 , strong nuclear staining (brown) of the adipocytes is observed with PPAR␥ antisera ( Figure 8B ) incubated with antiserum to PPAR␥ ( Figure 7B ) and RXR␣ (data not shown), but not antiserum to PPAR␣.
but not with preimmune sera ( Figure 8A ). The aortic sections shown in Figures 8C, 8D , and 8E show atheroThus, the CD36 promoter contains a bona fide binding site for the PPAR␥:RXR␣ complex.
sclerotic lesions characterized by the accumulation of macrophage-derived foam cells and lipid within the subcollectively suggest that PPAR␥ may play a role in the pathogenesis of atherosclerosis. endothelial space. In contrast to the normal cellular components of the vessel wall, the foam cells within these lesions show remarkably strong nuclear staining for PPAR␥ ( Figures 8C, 8D, and 8E) . Discussion The induction of PPAR␥ expression by oxLDL exposure, the ability of PPAR␥:RXR ligands to promote Coronary artery disease is the leading cause of death in industrialized societies. A detailed understanding of monocyte differentiation and uptake of oxLDL, and the high level of expression of PPAR␥ in foam cells in vivo the molecular and cellular events that underlie formation of the atherosclerotic plaque is a prerequisite to the therein). The subset of genes important for macrophage accumulation and metabolism of cholesterol and lipid rational design of therapeutics for this disease.
In this work, we have presented evidence implicating may be at least partially distinct from those important for inflammatory and immune responses. Interestingly, the nuclear receptor PPAR␥ in a novel signaling pathway that regulates differentiation and lipid metabolism in expression of a number of growth factors and cytokines has been reported to be influenced by oxLDL, including monocytic cells (Figure 9 ). PPAR␥ is induced in monocytes by exposure to oxLDL and is expressed at high TNF␣, IL-8, IL1-␤, and iNOS (Hamilton et al., 1995; Wang et al., 1996) . Our observation that oxLDL exposure inlevels in the foam cells of atherosclerotic lesions. Moreover, ligand activation of this receptor leads to a tranduces PPAR␥ expression suggests that PPAR␥ may be important for the modulation of gene expression in this scriptional induction of the scavenger receptor CD36 and endows cultured monocytes with the ability to bind context. In fact, we have recently demonstrated that certain oxidized lipid components of the oxLDL particle and internalize oxLDL. Together, these results suggest that PPAR␥ and its congeners may play an unexpected can function as endogenous activators of PPAR␥ (Nagy et al., 1998) . This observation reveals a novel mechanism role in the development of the atherosclerotic lesion.
Macrophages participate in diverse biologic processes, whereby oxLDL may modulate macrophage gene expression. including phagocytosis of pathogens and debris, antigen presentation, and regulation of the immune response While the association of a PPAR signaling pathway with macrophage lipid metabolism is unexpected, it fits through cytokine production. Subspecialization of macrophages likely involves distinct alterations in patterns well with the previously defined role for PPAR␥ in adipogenesis. Although prior work has focused primarily on of gene expression. For example, the osteoclast is a specialized macrophage-like cell that plays a central its role in adipocytes, it is likely that this nuclear receptor also functions as a regulator of lipid homeostasis in cerrole in bone remodeling. In this cell, the vitamin D receptor, another member of the nuclear hormone receptor tain other specialized cell types. Changes in lipid metabolism are a prominent feature of macrophage differentiasuperfamily, functions to regulate a specific set of genes involved in bone resorption (Ross et al., 1994) . During tion into foam cells. Such changes include increased free and esterified cholesterol content, increased content of atherogenesis, the deposition of large amounts of oxLDL within the arterial wall leads to the development lipoprotein oxidation products, expression of scavenger receptors, 15-lipoxygenase and lipoprotein lipase, and of another functionally specialized type of macrophage, the foam cell (Steinberg et al., 1989 , and references increases in acyl CoA: cholesterol acyltransferase (ACAT) TPA al., 1994 , and references therein). In addition to the scavenger receptor CD36 (this work), the lipoprotein lipase has recently been shown to occur on the SR-A promoter in U937 cells (Ricote et al., 1998) . The uptake of oxLDL gene has also been shown to be a target for PPAR␥ (Schoonjans et al., 1996) . in vivo likely requires integration of multiple signaling pathways, and therefore, the net effect of PPAR␥ and There is strong evidence that both SR-A and CD36 participate in the uptake of oxLDL in vivo (Nozaki et al., RXR agonists on macrophage uptake of oxLDL may vary between different cellular and hormonal contexts. Our 1995; Suzuki et al., 1997) . While expression of SR-A is restricted to macrophages, CD36 is expressed in a findings that CD36 is a direct target of PPAR␥, that exposure to oxLDL induces PPAR␥ expression, and that number of other cell types, including mammary epithelium and adipose tissue. This pattern of expression overthe oxLDL particle itself is a rich source of PPAR␥ activators (Nagy et al., 1998) , collectively suggest that PPAR␥ laps significantly with that of PPAR␥. Interestingly, CD36 is induced during the differentiation of preadipocytes may play a role in foam cell formation. Clearly, in vivo studies will be required to further address this possiand has been suggested to function as a fatty acid transporter in adipose tissue (Abumrad et al., 1993) . bility. Two groups have reported recently that PPAR␥ activa-CD36 expression is up-regulated by long chain fatty acids in preadipocyte cell lines (Sfeir et al., 1997) , and tors such as 15d-J2 and thiazolidinediones can inhibit production of certain inflammatory cytokines by TPAhas also been shown to be induced in murine models of diabetes and in mice maintained on a high-fat diet and IFN␥-activated macrophages in culture (Jiang et al., 1998; Ricote et al., 1998) . However, the molecular (Greenwalt et al., 1995) . Recently, it was reported that both native and modified LDL can induce CD36 expresmechanism involved in this inhibition and the implications of these observations for the physiologic role of sion in J774 macrophages by a transcriptional mechanism (Han et al., 1997) . All of these observations are PPAR␥ in monocytic cells are not clear. We have shown here that in undifferentiated myeloid precursors and consistent with our identification of CD36 as a PPAR␥ target gene.
resting monocytes PPAR␥ functions as an inducer of monocytic gene expression and differentiation. Thus, Previous work has demonstrated that expression of both the SR-A and CD36 genes is induced by M-CSF control of gene expression by PPAR␥ in this cell type is likely to involve both positive and negative regulation and TPA in THP-1 cells (Moulton et al., 1992; Yesner et al., 1996) . Surprisingly, however, we find that expression of target genes and to depend on the activation state of the cell. of these two proteins is differentially regulated by nuclear receptor pathways. CD36, but not SR-A, is tranAs an obligate heterodimeric DNA binding partner for a number of nuclear receptors, RXR stands at the crossscriptionally induced by PPAR␥ agonists in THP-1 cells. The combined stimulus of a PPAR␥ agonist and TPA roads of multiple cellular signaling pathways (Yu et al., 1991; Kliewer et al., 1992a; Leid et al., 1992 et al., 1995) . Total RNA was isolated using TRIzol reagent (GIBCOmissive heterodimer; Kurokawa et al., 1994; Forman et BRL) and Northern analysis was carried out as described (Tontonoz al., 1995b; Chen et al., 1996; Minucci et al., 1997 for both receptors (Kliewer et al., 1992b It is tempting to speculate that the elucidation of a (protein)/ml, and cells were incubated for an additional 2.5 hr at 4ЊC, nuclear receptor signaling pathway involved in macro- homeostasis and atherogenesis is complex, the influprotein and purified by glutathione affinity chromatography. The PPAR␥ fragment was purified from the GST carrier by thrombin ence of PPAR␥ and RXR ligands on systemic fatty acid, cleavage followed by FPLC. Rabbits were immunized by standard triglyceride and cholesterol metabolism, as well as their protocols. Total immunoglobulin was isolated from the crude antieffects on macrophage cytokine production, must also sera using the E-Z-Sep kit (Pharmacia) and immunoaffinity purified be taken into account. Clearly, in vivo studies will be using a resin prepared by coupling the N-terminal PPAR␥ protein required to determine whether agonists or antagonists fragment to Affigel 10/15 agarose beads (Bio-Rad). 3T3-L1 cells and of the PPAR␥:RXR pathway have potential utility in the human peripheral blood monocytes were cultured in multichamber wells and processed for indirect immunofluorescence as follows.
treatment or prevention of atherosclerosis.
Cells were fixed in chilled acetone for 20 min. Antibodies were diluted in 20 mM Tris (pH 7.5), 0.5 M NaCl, 2% BSA, and 2 % nonfat dry milk. Affinity-purified rabbit anti-human PPAR␥ antibody was Experimental Procedures applied at a dilution of 1:50 at 4ЊC overnight followed by an FITClabeled donkey anti-rabbit IgG (Jackson) diluted 1:80 for 45 min. Cell Culture and RNA Analysis HL60 and THP-1 cells were obtained from ATCC and cultured in
For tissue localization studies, cryostat sections of paraformaldehyde fixed tissue samples of LDLR Ϫ/Ϫ ;Tg(apoB);Tg(apoa) mice were RPMI containing 10% fetal calf serum (Summit), penicillin, and streptomycin in an atmosphere of 7% CO 2. Human peripheral blood used (Sanan et al., 1998) . Endogenous peroxidase was blocked with
